<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plospath</journal-id>
<journal-title-group>
<journal-title>PLOS Pathogens</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-7366</issn>
<issn pub-type="epub">1553-7374</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.ppat.1005953</article-id>
<article-id pub-id-type="publisher-id">PPATHOGENS-D-16-02022</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Opinion</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>DNA</subject><subj-group><subject>DNA repair</subject><subj-group><subject>Non-homologous end joining</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Nucleic acids</subject><subj-group><subject>DNA</subject><subj-group><subject>DNA repair</subject><subj-group><subject>Non-homologous end joining</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>DNA</subject><subj-group><subject>DNA recombination</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Nucleic acids</subject><subj-group><subject>DNA</subject><subj-group><subject>DNA recombination</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Epigenetics</subject><subj-group><subject>RNA interference</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject><subj-group><subject>RNA interference</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genetic interference</subject><subj-group><subject>RNA interference</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Nucleic acids</subject><subj-group><subject>RNA</subject><subj-group><subject>RNA interference</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>DNA viruses</subject><subj-group><subject>Herpesviruses</subject><subj-group><subject>Epstein-Barr virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Herpesviruses</subject><subj-group><subject>Epstein-Barr virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Herpesviruses</subject><subj-group><subject>Epstein-Barr virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Herpesviruses</subject><subj-group><subject>Epstein-Barr virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Hepatitis viruses</subject><subj-group><subject>Hepatitis B virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Hepatitis viruses</subject><subj-group><subject>Hepatitis B virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Hepatitis viruses</subject><subj-group><subject>Hepatitis B virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Recombinant proteins</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral replication</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>White</surname>
<given-names>Martyn K.</given-names>
</name>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Hu</surname>
<given-names>Wenhui</given-names>
</name>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Khalili</surname>
<given-names>Kamel</given-names>
</name>
<xref ref-type="corresp" rid="cor001">*</xref>
<xref ref-type="aff" rid="aff001"/>
</contrib>
</contrib-group>
<aff id="aff001"><addr-line>Department of Neuroscience, Center for Neurovirology and Comprehensive NeuroAIDS Center, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Coyne</surname>
<given-names>Carolyn B</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Pittsburgh, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>KK and WH are named on patents related to viral gene editing.  KK is a cofounder and holds equity in Excision Biotherapeutics - a startup where he and WH serve as scientific advisors.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">kamel.khalili@temple.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>8</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>12</month>
<year>2016</year>
</pub-date>
<volume>12</volume>
<issue>12</issue>
<elocation-id>e1005953</elocation-id>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>White et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.ppat.1005953"/>
<funding-group>
<funding-statement>The authors received no specific funding for this work.</funding-statement>
</funding-group>
<counts>
<fig-count count="1"/>
<table-count count="1"/>
<page-count count="10"/>
</counts>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Powerful new gene editing techniques promise groundbreaking opportunities for novel therapeutic options to important illnesses, including cancer, genetic disorders [<xref ref-type="bibr" rid="ppat.1005953.ref001">1</xref>], and viral infections [<xref ref-type="bibr" rid="ppat.1005953.ref002">2</xref>]. These techniques include zinc finger nucleases (ZFN) [<xref ref-type="bibr" rid="ppat.1005953.ref003">3</xref>], transcription activator-like effector nucleases (TALEN) [<xref ref-type="bibr" rid="ppat.1005953.ref004">4</xref>], and clustered regulatory interspaced short palindromic repeat (CRISPR)-associated 9 (Cas9) [<xref ref-type="bibr" rid="ppat.1005953.ref005">5</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref006">6</xref>]. In particular, CRISPR/Cas9 provides an effective, highly specific, and versatile tool applicable to important human viruses, including HIV-1 [<xref ref-type="bibr" rid="ppat.1005953.ref007">7</xref>]. CRISPR/Cas9 is elegant and simple compared to ZFN and TALEN because it uses one or more guide RNAs (gRNA), which are simple to produce and specifically target any sequence in an adaptable and flexible way for different targets, such as viral genes, by changing the gRNA sequence [<xref ref-type="bibr" rid="ppat.1005953.ref008">8</xref>].</p>
<p>Cas9 cuts both strands of the DNA target, resulting in a double-strand break (DSB), usually repaired by nonhomologous end-joining (NHEJ), an error-prone arm of the DNA repair pathway that introduces insertions and deletions (InDels) at the break site. While InDel introduction is quite rare, the products of accurate repair are targets for recleavage by CRISPR/Cas9, whereas InDel products are not, and, hence, InDel products accumulate with repeated cleavage cycles [<xref ref-type="bibr" rid="ppat.1005953.ref009">9</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref010">10</xref>].</p>
<p>In this short review, we discuss CRISPR/Cas9 in combating human viruses by specifically targeting and disrupting essential viral genes. We will also discuss generation of viral escape mutants resistant to Cas9/gRNA and how this may be overcome.</p>
</sec>
<sec id="sec002">
<title>Application to Human Viruses</title>
<p>Genetic editing applications, including CRISPR/Cas9, can disrupt both episomal and integrated DNA viruses and can be applied to several human viruses [<xref ref-type="bibr" rid="ppat.1005953.ref002">2</xref>], including papillomaviruses HPV16 and HPV18 [<xref ref-type="bibr" rid="ppat.1005953.ref011">11</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref013">13</xref>], hepatitis B virus (HBV) [<xref ref-type="bibr" rid="ppat.1005953.ref014">14</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref017">17</xref>], Epstein-Barr virus (EBV) [<xref ref-type="bibr" rid="ppat.1005953.ref018">18</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref019">19</xref>], HIV-1 [<xref ref-type="bibr" rid="ppat.1005953.ref007">7</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref020">20</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref027">27</xref>], polyomavirus JC (JCV) [<xref ref-type="bibr" rid="ppat.1005953.ref028">28</xref>], Herpes simplex virus-1 [<xref ref-type="bibr" rid="ppat.1005953.ref029">29</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref030">30</xref>], and other herpesviruses [<xref ref-type="bibr" rid="ppat.1005953.ref030">30</xref>].</p>
<p>HPV16 and HPV18 are DNA viruses that cause cervical carcinoma through viral proteins E6 and E7. CRISPR/Cas9 targeting HPV E6 and E7 genes is effective with HPV-transformed cell lines and is potentially applicable to effective clinical therapy for HPV-associated tumors [<xref ref-type="bibr" rid="ppat.1005953.ref012">12</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref014">14</xref>]. HBV is a DNA virus and causes acute and chronic liver infections and hepatocellular carcinoma (HCC). CRISPR/Cas9 can disrupt HBV in vitro and in vivo and has potential in the eradication of persistent HBV infections [<xref ref-type="bibr" rid="ppat.1005953.ref011">11</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref013">13</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref015">15</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref016">16</xref>]. EBV is a herpesvirus and causes Burkitt’s lymphoma and nasopharyngeal carcinoma. CRISPR/Cas9 can ablate expression of EBV genes and is feasible as an approach to EBV infection [<xref ref-type="bibr" rid="ppat.1005953.ref018">18</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref019">19</xref>].</p>
<p>HIV provirus permanently integrates into the host genome and becomes a persistent viral reservoir with potential to reactivate and cause disease anew, making HIV-1/AIDS a chronic, lifelong infection refractory to the immune system and antiviral drug regimens. CRISPR/Cas9 allows the excision of segments of integrated proviral DNA in different latently infected cell types by targeting sequences within the HIV-1 long terminal repeat (LTR) flanking the provirus and allowing complete provirus excision [<xref ref-type="bibr" rid="ppat.1005953.ref020">20</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref022">22</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref024">24</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref026">26</xref>]. These experiments were performed with T cells [<xref ref-type="bibr" rid="ppat.1005953.ref020">20</xref>], microglia, promonocytic T cells [<xref ref-type="bibr" rid="ppat.1005953.ref021">21</xref>], primary CD4+ T-cells cultured ex vivo [<xref ref-type="bibr" rid="ppat.1005953.ref022">22</xref>], induced pluripotent stem cells [<xref ref-type="bibr" rid="ppat.1005953.ref024">24</xref>], HEK293T cells [<xref ref-type="bibr" rid="ppat.1005953.ref025">25</xref>], and Jurkat cells [<xref ref-type="bibr" rid="ppat.1005953.ref026">26</xref>], indicating that the ability of CRISPR/Cas9 to excise HIV provirus is not restricted by cell-type–specific factors. While the fate of the eliminated DNA arising after excision of segments of integrated proviral DNA is not known for certain, we tend to think that after excision from the genome, it will be degraded. Thus, there is no published evidence that extrachromosomal double-stranded circles resulting from excision can integrate back into the chromosomal DNA. For example, we recently used CRISPR/Cas9 gene editing to eliminate HIV-1 genomes from human T-lymphoid cells and comprehensively assessed the HIV-1 eradicated cells by whole-genome sequencing to rule out any off-target effects [<xref ref-type="bibr" rid="ppat.1005953.ref022">22</xref>]. No reintegrated viral DNA was found in this study.</p>
<p>The CRISPR/Cas9 approach has also allowed uninfected cells to be prophylactically protected against HIV infection [<xref ref-type="bibr" rid="ppat.1005953.ref021">21</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref022">22</xref>]. CRISPR/Cas9 was used in two murine models in which tail-vein or intraperitoneal injection of transgenic animals with virus vector expressing Cas9 and a multiplex of gRNAs resulted in the cleavage of integrated HIV-1 DNA provirus in many tissues, indicating proof-of-concept for in vivo eradication of integrated HIV-1 DNA by CRISPR/Cas9 [<xref ref-type="bibr" rid="ppat.1005953.ref023">23</xref>]. Kaminski et al [<xref ref-type="bibr" rid="ppat.1005953.ref027">27</xref>] personalized CRISPR/Cas9 activity by placing the Cas9 gene under the control of an HIV-1 promoter, which is activated by the HIV-1 Tat. Functional activation of CRISPR/Cas9 by Tat occurred during HIV-1 infection, resulting in the excision of a designated segment of integrated HIV-1 proviral DNA and consequently suppressing viral expression [<xref ref-type="bibr" rid="ppat.1005953.ref027">27</xref>]. Thus, regulated expression of Cas9 by Tat provides a novel and safe strategy for ablation of HIV-1 at an early stage of acute infection and silent proviral reactivation in latently infected cells.</p>
<p>In addition to CRISPR/Cas9, the Cre recombinase gene editing approach can be used against HIV-1. This approach uses Cre recombinase from bacteriophage P1 to carry out site-specific recombination between two DNA recognition sites, known as LoxP sites, allowing precise manipulation of genomes, and has been used widely in mouse genetics [<xref ref-type="bibr" rid="ppat.1005953.ref031">31</xref>]. Cre target specificity can be manipulated to generate novel site-specific recombinases via directed evolution [<xref ref-type="bibr" rid="ppat.1005953.ref032">32</xref>] using substrate-linked protein evolution (SLiPE), which places the recombination target site of interest adjacent to the recombinase coding region, allowing DNA molecules with a successful recombinase coding region to be marked on the linked substrate DNA and recovered from the background of unsuccessful recombinases by PCR [<xref ref-type="bibr" rid="ppat.1005953.ref032">32</xref>]. SLiPE has been employed to evolve recombinase-recognizing sequences within an HIV-1 LTR to efficiently excise integrated HIV-1 provirus from latently infected cells [<xref ref-type="bibr" rid="ppat.1005953.ref033">33</xref>]. LTR-specific recombinase (Tre-recombinase) is proven to be a promising tool for excision of HIV-1 provirus from infected cells [<xref ref-type="bibr" rid="ppat.1005953.ref033">33</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref034">34</xref>]. Hauber et al. [<xref ref-type="bibr" rid="ppat.1005953.ref034">34</xref>] reported conditional expression of a Tre-recombinase from self-inactivating lentivirus in HIV-infected cells, which resulted in HIV-1 provirus excision that was effective in vivo in humanized Rag2<sup>-/-</sup>,γ<sup>-/-</sup> mice engrafted with either Tre-transduced primary CD4<sup>+</sup> or CD34<sup>+</sup> cells [<xref ref-type="bibr" rid="ppat.1005953.ref035">35</xref>]. Karpinski et al. [<xref ref-type="bibr" rid="ppat.1005953.ref036">36</xref>] used SLiPE to evolve a novel recombinase (Brec1) able to recognize a sequence present in most clinically relevant HIV-1 LTRs subtypes and strains, which excised integrated HIV-1 provirus for a number of clinical isolates of HIV-1 in vitro and in vivo, including mice humanized with cells from patients [<xref ref-type="bibr" rid="ppat.1005953.ref036">36</xref>].</p>
<p>The recombinase and CRISPR/Cas9 approaches are suitable for use with either double-stranded (ds) DNA viruses or retroviruses that have dsDNA as part of the life cycle (HIV-1). However, Cas9 endonuclease from <italic>Francisella novicida</italic> can target RNA and inhibits the RNA virus hepatitis C [<xref ref-type="bibr" rid="ppat.1005953.ref037">37</xref>], and it may be applicable to other human RNA viruses [<xref ref-type="bibr" rid="ppat.1005953.ref038">38</xref>].</p>
</sec>
<sec id="sec003">
<title>The Problem of Viral Escape</title>
<p>Several reports have highlighted a caveat in CRISPR/Cas9 that is important to address when choosing gene editing strategy. CRISPR/Cas9 targeting of HIV-1 generated mutant viruses able to escape and replicate [<xref ref-type="bibr" rid="ppat.1005953.ref039">39</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref042">42</xref>], as observed earlier with RNAi approaches [<xref ref-type="bibr" rid="ppat.1005953.ref043">43</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref045">45</xref>]. One report described a mutant HIV-1 generated after ZFN therapy [<xref ref-type="bibr" rid="ppat.1005953.ref039">39</xref>], and other reports indicated CRISPR/Cas9 gave profound suppression of HIV replication, but escape mutations were rapidly and consistently generated [<xref ref-type="bibr" rid="ppat.1005953.ref040">40</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref042">42</xref>]. Escape mutants arose by insertions, deletions, and substitutions (InDels) located within the target site for Cas9 cleavage and are typical for DSBs repaired by NHEJ [<xref ref-type="bibr" rid="ppat.1005953.ref040">40</xref>]. Cas9 cleavage inactivates the virus by introduction of mutations by NHEJ, but a subset of these retain viability and escape and are no longer susceptible to the original gRNA. Interestingly, while most InDels contributing to escape at non-coding regions were a single base pair, three base pair InDels were observed when the target was within an HIV-1 coding region; i.e., the InDel event may preserve the HIV-1 open reading frame but destroy the CRISPR gRNA sequence homology [<xref ref-type="bibr" rid="ppat.1005953.ref042">42</xref>]. The occurrence of InDel escape mutations is a consequence of NHEJ DNA repair and so may also occur for any DNA virus or retrovirus and, indeed, was recently reported for the pseudorabies herpesvirus [<xref ref-type="bibr" rid="ppat.1005953.ref046">46</xref>]. NHEJ is almost always the dominant mode of DNA repair [<xref ref-type="bibr" rid="ppat.1005953.ref047">47</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref048">48</xref>] and is the desired pathway of repair of CRISPR/Cas9-generated DSBs, because the purpose of CRISPR/Cas9 is to introduce mutations and inactivate viruses. It is also important to note that DSB and NHEJ repairs may have very different rates in some cells as compared to other cell types; e.g., T-cells relative to myeloid cells [<xref ref-type="bibr" rid="ppat.1005953.ref049">49</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref050">50</xref>]. However, as noted above, in studies of HIV-1 provirus excision, no cell-type-specific differences were observed.</p>
</sec>
<sec id="sec004">
<title>Strategies to Combat Viral Escape</title>
<p>Viral escape is not insurmountable if an appropriate choice of gene editing strategy is adopted. InDels introduced by NHEJ following CRISPR/Cas9 cleavage can cause frameshifts or premature stop codons, disrupting the target gene and abrogating its function and viral viability. If a unique locus is targeted, there is a significant possibility that InDels will be generated that allow viral escape; however, if multiplex gRNAs are employed, then the probability of this is greatly reduced, because the chances of two or more viability-conferring mutations are much less, as seen for mutiplex RNA interference (RNAi) [<xref ref-type="bibr" rid="ppat.1005953.ref051">51</xref>]. Alternatively, if two gRNAs produce DNA breaks, allowing excision of a large section of DNA, this will permanently prevent the occurrence of escape mutations, as shown in <xref ref-type="fig" rid="ppat.1005953.g001">Fig 1</xref>. Several studies have demonstrated the strong suppression of HIV-1 using a multiplex approach [<xref ref-type="bibr" rid="ppat.1005953.ref021">21</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref025">25</xref>]. <xref ref-type="table" rid="ppat.1005953.t001">Table 1</xref> summarizes recent studies [<xref ref-type="bibr" rid="ppat.1005953.ref052">52</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref075">75</xref>] on the use of CRISPR/Cas9 technology for editing several human viruses using single and multiplex gRNAs, resulting in the introduction of InDels and/or excision of the segment of the viral genome.</p>
<fig id="ppat.1005953.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1005953.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Schematic of the CRIPSR/Cas9 approach to viral inactivation and generation of escape mutants.</title>
<p>CRISPR/Cas9 endonuclease can be used to cut a viral genome within an essential target gene using either a single gRNA (<bold>A</bold>) or multiple gRNAs (<bold>B</bold>). With a single gRNA, a base substitution or InDel mutation may occur on repair of the double-strand DNA break by error-prone non-homologous end-joining (NHEJ), which inactivates the virus. However, it is also possible that cleavage at a single site and error-prone NHEJ may also allow the occurrence and selection of escape mutants (<bold>A</bold>). However, when multiple gRNAs are used, this allows the creation of a large deletion with no protein produced and no possibility of escape mutations occurring (<bold>B</bold>).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005953.g001" xlink:type="simple"/>
</fig>
<table-wrap id="ppat.1005953.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1005953.t001</object-id>
<label>Table 1</label> <caption><title>Human viral targets of CRISPR/Cas9.</title></caption>
<alternatives>
<graphic id="ppat.1005953.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005953.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Virus</th>
<th align="center">Target</th>
<th align="center" colspan="2">gRNAs</th>
<th align="center" colspan="2">Inhibitory effects</th>
<th align="center">Reference</th>
</tr>
<tr>
<th align="center"/>
<th align="center"/>
<th align="center">Monoplex (InDel)</th>
<th align="center">Multiplex (InDel/excision)</th>
<th align="center">In vitro</th>
<th align="center">In vivo</th>
<th align="center"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" style="background-color:#DBDBDB"/>
<td align="left" style="background-color:#DBDBDB">-IFI16</td>
<td align="center" style="background-color:#DBDBDB">-</td>
<td align="center" style="background-color:#DBDBDB">+</td>
<td align="center" style="background-color:#DBDBDB">+++</td>
<td align="center" style="background-color:#DBDBDB">ND</td>
<td align="left" style="background-color:#DBDBDB">[<xref ref-type="bibr" rid="ppat.1005953.ref052">52</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#DBDBDB"/>
<td align="left" style="background-color:#DBDBDB"/>
<td align="center" style="background-color:#DBDBDB"/>
<td align="center" style="background-color:#DBDBDB"/>
<td align="center" style="background-color:#DBDBDB"/>
<td align="center" style="background-color:#DBDBDB"/>
<td align="left" style="background-color:#DBDBDB"/>
</tr>
<tr>
<td align="left" style="background-color:#DBDBDB">HSV-1</td>
<td align="left" style="background-color:#DBDBDB">-Torsin A and B</td>
<td align="center" style="background-color:#DBDBDB">+</td>
<td align="center" style="background-color:#DBDBDB">-</td>
<td align="center" style="background-color:#DBDBDB">+++</td>
<td align="center" style="background-color:#DBDBDB">ND</td>
<td align="left" style="background-color:#DBDBDB">[<xref ref-type="bibr" rid="ppat.1005953.ref053">53</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#DBDBDB"/>
<td align="left" style="background-color:#DBDBDB">LAP1, LULL1</td>
<td align="center" style="background-color:#DBDBDB"/>
<td align="center" style="background-color:#DBDBDB"/>
<td align="center" style="background-color:#DBDBDB"/>
<td align="center" style="background-color:#DBDBDB"/>
<td align="left" style="background-color:#DBDBDB"/>
</tr>
<tr>
<td align="left" style="background-color:#DBDBDB"/>
<td align="left" style="background-color:#DBDBDB"/>
<td align="center" style="background-color:#DBDBDB"/>
<td align="center" style="background-color:#DBDBDB"/>
<td align="center" style="background-color:#DBDBDB"/>
<td align="center" style="background-color:#DBDBDB"/>
<td align="left" style="background-color:#DBDBDB"/>
</tr>
<tr>
<td align="left" style="background-color:#DBDBDB"/>
<td align="left" style="background-color:#DBDBDB">-ICP0, ICP4, ICP27</td>
<td align="center" style="background-color:#DBDBDB">+</td>
<td align="center" style="background-color:#DBDBDB">+</td>
<td align="center" style="background-color:#DBDBDB">+++</td>
<td align="center" style="background-color:#DBDBDB">ND</td>
<td align="left" style="background-color:#DBDBDB">[<xref ref-type="bibr" rid="ppat.1005953.ref029">29</xref>]</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="left"/>
</tr>
<tr>
<td align="left" style="background-color:#C5E0B3"/>
<td align="left" style="background-color:#C5E0B3">-Promoter, E6, E7 (HPV16)</td>
<td align="center" style="background-color:#C5E0B3">+</td>
<td align="center" style="background-color:#C5E0B3">+</td>
<td align="center" style="background-color:#C5E0B3">+++</td>
<td align="center" style="background-color:#C5E0B3">ND</td>
<td align="left" style="background-color:#C5E0B3">[<xref ref-type="bibr" rid="ppat.1005953.ref013">13</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#C5E0B3"/>
<td align="left" style="background-color:#C5E0B3"/>
<td align="center" style="background-color:#C5E0B3"/>
<td align="center" style="background-color:#C5E0B3"/>
<td align="center" style="background-color:#C5E0B3"/>
<td align="center" style="background-color:#C5E0B3"/>
<td align="left" style="background-color:#C5E0B3"/>
</tr>
<tr>
<td align="left" style="background-color:#C5E0B3"/>
<td align="left" style="background-color:#C5E0B3">-E6, E7 (HPV16, 18)</td>
<td align="center" style="background-color:#C5E0B3">+</td>
<td align="center" style="background-color:#C5E0B3">-</td>
<td align="center" style="background-color:#C5E0B3">+++</td>
<td align="center" style="background-color:#C5E0B3">ND</td>
<td align="left" style="background-color:#C5E0B3">[<xref ref-type="bibr" rid="ppat.1005953.ref011">11</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#C5E0B3">HPV</td>
<td align="left" style="background-color:#C5E0B3"/>
<td align="center" style="background-color:#C5E0B3"/>
<td align="center" style="background-color:#C5E0B3"/>
<td align="center" style="background-color:#C5E0B3"/>
<td align="center" style="background-color:#C5E0B3"/>
<td align="left" style="background-color:#C5E0B3"/>
</tr>
<tr>
<td align="left" style="background-color:#C5E0B3"/>
<td align="left" style="background-color:#C5E0B3">-E6, E7 (HPV16)</td>
<td align="center" style="background-color:#C5E0B3">+</td>
<td align="center" style="background-color:#C5E0B3">-</td>
<td align="center" style="background-color:#C5E0B3">++</td>
<td align="center" style="background-color:#C5E0B3">ND</td>
<td align="left" style="background-color:#C5E0B3">[<xref ref-type="bibr" rid="ppat.1005953.ref012">12</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref054">54</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#C5E0B3"/>
<td align="left" style="background-color:#C5E0B3"/>
<td align="center" style="background-color:#C5E0B3"/>
<td align="center" style="background-color:#C5E0B3"/>
<td align="center" style="background-color:#C5E0B3"/>
<td align="center" style="background-color:#C5E0B3"/>
<td align="left" style="background-color:#C5E0B3"/>
</tr>
<tr>
<td align="left" style="background-color:#C5E0B3"/>
<td align="left" style="background-color:#C5E0B3">E7 (HPV6, HPV11)</td>
<td align="center" style="background-color:#C5E0B3">+</td>
<td align="center" style="background-color:#C5E0B3">-</td>
<td align="center" style="background-color:#C5E0B3">++</td>
<td align="center" style="background-color:#C5E0B3">ND</td>
<td align="left" style="background-color:#C5E0B3">[<xref ref-type="bibr" rid="ppat.1005953.ref055">55</xref>]</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="left"/>
</tr>
<tr>
<td align="left" style="background-color:#DEEAF6"/>
<td align="left" style="background-color:#DEEAF6">-cccDNA</td>
<td align="center" style="background-color:#DEEAF6">-</td>
<td align="center" style="background-color:#DEEAF6">+</td>
<td align="center" style="background-color:#DEEAF6">+++</td>
<td align="center" style="background-color:#DEEAF6">+++</td>
<td align="left" style="background-color:#DEEAF6">[<xref ref-type="bibr" rid="ppat.1005953.ref014">14</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref016">16</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref056">56</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref061">61</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#DEEAF6"/>
<td align="left" style="background-color:#DEEAF6"/>
<td align="center" style="background-color:#DEEAF6"/>
<td align="center" style="background-color:#DEEAF6"/>
<td align="center" style="background-color:#DEEAF6"/>
<td align="center" style="background-color:#DEEAF6"/>
<td align="left" style="background-color:#DEEAF6"/>
</tr>
<tr>
<td align="left" style="background-color:#DEEAF6">HBV</td>
<td align="left" style="background-color:#DEEAF6">-HBsAg</td>
<td align="center" style="background-color:#DEEAF6">+</td>
<td align="center" style="background-color:#DEEAF6">-</td>
<td align="center" style="background-color:#DEEAF6">++</td>
<td align="center" style="background-color:#DEEAF6">++</td>
<td align="left" style="background-color:#DEEAF6">[<xref ref-type="bibr" rid="ppat.1005953.ref017">17</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref062">62</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#DEEAF6"/>
<td align="left" style="background-color:#DEEAF6"/>
<td align="center" style="background-color:#DEEAF6"/>
<td align="center" style="background-color:#DEEAF6"/>
<td align="center" style="background-color:#DEEAF6"/>
<td align="center" style="background-color:#DEEAF6"/>
<td align="left" style="background-color:#DEEAF6"/>
</tr>
<tr>
<td align="left" style="background-color:#DEEAF6"/>
<td align="left" style="background-color:#DEEAF6">-S, X</td>
<td align="center" style="background-color:#DEEAF6">+</td>
<td align="center" style="background-color:#DEEAF6">-</td>
<td align="center" style="background-color:#DEEAF6">++</td>
<td align="center" style="background-color:#DEEAF6">++</td>
<td align="left" style="background-color:#DEEAF6">[<xref ref-type="bibr" rid="ppat.1005953.ref063">63</xref>]</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="left"/>
</tr>
<tr>
<td align="left" style="background-color:#FFFFCC">HCV</td>
<td align="left" style="background-color:#FFFFCC">-host factor, (CLDN1, OCLN, mir122)</td>
<td align="center" style="background-color:#FFFFCC">+</td>
<td align="center" style="background-color:#FFFFCC">-</td>
<td align="center" style="background-color:#FFFFCC">+++</td>
<td align="center" style="background-color:#FFFFCC">ND</td>
<td align="left" style="background-color:#FFFFCC">[<xref ref-type="bibr" rid="ppat.1005953.ref064">64</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref066">66</xref>]</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="left"/>
</tr>
<tr>
<td align="left" style="background-color:#FFF2CC"/>
<td align="left" style="background-color:#FFF2CC">-BART</td>
<td align="center" style="background-color:#FFF2CC">-</td>
<td align="center" style="background-color:#FFF2CC">+</td>
<td align="center" style="background-color:#FFF2CC">+++</td>
<td align="center" style="background-color:#FFF2CC">ND</td>
<td align="left" style="background-color:#FFF2CC">[<xref ref-type="bibr" rid="ppat.1005953.ref019">19</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FFF2CC">EBV</td>
<td align="left" style="background-color:#FFF2CC"/>
<td align="center" style="background-color:#FFF2CC"/>
<td align="center" style="background-color:#FFF2CC"/>
<td align="center" style="background-color:#FFF2CC"/>
<td align="center" style="background-color:#FFF2CC"/>
<td align="left" style="background-color:#FFF2CC"/>
</tr>
<tr>
<td align="left" style="background-color:#FFF2CC"/>
<td align="left" style="background-color:#FFF2CC">-BVRF1</td>
<td align="center" style="background-color:#FFF2CC">+</td>
<td align="center" style="background-color:#FFF2CC">-</td>
<td align="center" style="background-color:#FFF2CC">++</td>
<td align="center" style="background-color:#FFF2CC">ND</td>
<td align="left" style="background-color:#FFF2CC">[<xref ref-type="bibr" rid="ppat.1005953.ref067">67</xref>]</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="left"/>
</tr>
<tr>
<td align="left" style="background-color:#D9D9D9">JCV</td>
<td align="left" style="background-color:#D9D9D9">-T-antigen</td>
<td align="center" style="background-color:#D9D9D9">+</td>
<td align="center" style="background-color:#D9D9D9">+</td>
<td align="center" style="background-color:#D9D9D9">+++</td>
<td align="center" style="background-color:#D9D9D9">ND</td>
<td align="left" style="background-color:#D9D9D9">[<xref ref-type="bibr" rid="ppat.1005953.ref028">28</xref>]</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="left"/>
</tr>
<tr>
<td align="left" style="background-color:#FBE4D5"/>
<td align="left" style="background-color:#FBE4D5">-LTR</td>
<td align="center" style="background-color:#FBE4D5">+</td>
<td align="center" style="background-color:#FBE4D5">+</td>
<td align="center" style="background-color:#FBE4D5">+++</td>
<td align="center" style="background-color:#FBE4D5">ND</td>
<td align="justify" style="background-color:#FBE4D5">[<xref ref-type="bibr" rid="ppat.1005953.ref020">20</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref022">22</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref025">25</xref>,<xref ref-type="bibr" rid="ppat.1005953.ref026">26</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref068">68</xref>,<xref ref-type="bibr" rid="ppat.1005953.ref069">69</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FBE4D5"/>
<td align="left" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="justify" style="background-color:#FBE4D5"/>
</tr>
<tr>
<td align="left" style="background-color:#FBE4D5"/>
<td align="left" style="background-color:#FBE4D5">-LTR</td>
<td align="center" style="background-color:#FBE4D5">+</td>
<td align="center" style="background-color:#FBE4D5">-</td>
<td align="center" style="background-color:#FBE4D5">++</td>
<td align="center" style="background-color:#FBE4D5">ND</td>
<td align="left" style="background-color:#FBE4D5">[<xref ref-type="bibr" rid="ppat.1005953.ref040">40</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref041">41</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FBE4D5"/>
<td align="left" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="justify" style="background-color:#FBE4D5"/>
</tr>
<tr>
<td align="left" style="background-color:#FBE4D5">HIV-1</td>
<td align="left" style="background-color:#FBE4D5">-Gag/Pol</td>
<td align="center" style="background-color:#FBE4D5">+</td>
<td align="center" style="background-color:#FBE4D5">+</td>
<td align="center" style="background-color:#FBE4D5">+++</td>
<td align="center" style="background-color:#FBE4D5">ND</td>
<td align="left" style="background-color:#FBE4D5">[<xref ref-type="bibr" rid="ppat.1005953.ref025">25</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref026">26</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FBE4D5"/>
<td align="left" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="justify" style="background-color:#FBE4D5"/>
</tr>
<tr>
<td align="left" style="background-color:#FBE4D5"/>
<td align="left" style="background-color:#FBE4D5">-Env, Tat, Rev</td>
<td align="center" style="background-color:#FBE4D5">+</td>
<td align="center" style="background-color:#FBE4D5">-</td>
<td align="center" style="background-color:#FBE4D5">+++</td>
<td align="center" style="background-color:#FBE4D5">ND</td>
<td align="left" style="background-color:#FBE4D5">[<xref ref-type="bibr" rid="ppat.1005953.ref026">26</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FBE4D5"/>
<td align="left" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="justify" style="background-color:#FBE4D5"/>
</tr>
<tr>
<td align="left" style="background-color:#FBE4D5"/>
<td align="left" style="background-color:#FBE4D5">-host factors (CCR5, CXCR4, SAMHD1)</td>
<td align="center" style="background-color:#FBE4D5">+</td>
<td align="center" style="background-color:#FBE4D5">-</td>
<td align="center" style="background-color:#FBE4D5">++</td>
<td align="center" style="background-color:#FBE4D5">ND</td>
<td align="left" style="background-color:#FBE4D5">[<xref ref-type="bibr" rid="ppat.1005953.ref070">70</xref>–<xref ref-type="bibr" rid="ppat.1005953.ref075">75</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FBE4D5"/>
<td align="left" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="center" style="background-color:#FBE4D5"/>
<td align="justify" style="background-color:#FBE4D5"/>
</tr>
<tr>
<td align="left" style="background-color:#FBE4D5"/>
<td align="left" style="background-color:#FBE4D5">-LTR/Gag D</td>
<td align="center" style="background-color:#FBE4D5">-</td>
<td align="center" style="background-color:#FBE4D5">+</td>
<td align="center" style="background-color:#FBE4D5">++</td>
<td align="center" style="background-color:#FBE4D5">++</td>
<td align="left" style="background-color:#FBE4D5">[<xref ref-type="bibr" rid="ppat.1005953.ref023">23</xref>]</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>ND: Not determined</p></fn>
<fn id="t001fn002"><p>+ indicates experiment performed,—indicates no experiment</p></fn>
<fn id="t001fn003"><p>Inhibitory Effect: +++: Strong; ++: Moderate</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Another approach is engineering of new Cas9 variants that cleave at a site outside the target so mutations from NHEJ will not prevent binding and cleavage of Cas9 [<xref ref-type="bibr" rid="ppat.1005953.ref076">76</xref>]; e.g., Cpf1 cleaves a region distal from target [<xref ref-type="bibr" rid="ppat.1005953.ref077">77</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref078">78</xref>]. Another possibility is to combine CRISPR/Cas9 with RNAi to apply a double assault. RNAi approaches exist for a number of viruses, including HIV-1 [<xref ref-type="bibr" rid="ppat.1005953.ref043">43</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref079">79</xref>], HBV [<xref ref-type="bibr" rid="ppat.1005953.ref080">80</xref>], HCV [<xref ref-type="bibr" rid="ppat.1005953.ref081">81</xref>], HPV [<xref ref-type="bibr" rid="ppat.1005953.ref082">82</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref083">83</xref>], JCV [<xref ref-type="bibr" rid="ppat.1005953.ref084">84</xref>], and HSV [<xref ref-type="bibr" rid="ppat.1005953.ref085">85</xref>]. For example, RNAi against HIV-1 is already reaching the clinic [<xref ref-type="bibr" rid="ppat.1005953.ref043">43</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref079">79</xref>]. Delivery and the production of escape mutants are a problem, but combination of RNAi and CRISPR/Cas9 may address these problems. Delivery of both could be performed at the same time, and, just as multiplexing gRNAs has advantages, so the combination of RNAi and CRISPR/Cas9 has advantages over either approach employed alone. Another advantage would be that reduction in viral replication rate by RNAi would be expected to reduce the viral replication rate and viral titer and, hence, render virus more susceptible to CRISPR/Cas9 cleavage [<xref ref-type="bibr" rid="ppat.1005953.ref068">68</xref>]. Thus, the combined use of an agent such as RNAi or a small molecule antiviral that slows viral replication may enhance the efficacy of CRISPR. HIV-positive subjects eligible for treatment with CRISPR/Cas9 would also use combined antiretroviral therapy, which would significantly improve the efficacy of CRISPR/Cas9 alleviating concerns related to resistance conferred by high rates of viral replication.</p>
<p>Finally, two other approaches have been applied that should not be affected by CRISPR/Cas9-generated escape mutants. In the case of HIV-1, CRISPR/Cas9 can disrupt cellular HIV coreceptors, CCR5 and CXCR4 [<xref ref-type="bibr" rid="ppat.1005953.ref071">71</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref086">86</xref>]; cells become refractory to HIV infection, and CRISPR/Cas9 would not be expected to generate escape mutants. Another approach is the use of Cas9 mutants deficient in endonuclease activity with a transcriptional activation domain (VP64) to target the HIV promoter region in a "shock and kill" strategy [<xref ref-type="bibr" rid="ppat.1005953.ref087">87</xref>, <xref ref-type="bibr" rid="ppat.1005953.ref088">88</xref>]. Because the mutant Cas9 has no nuclease activity, there is no possibility of escape mutants being generated.</p>
<p>In conclusion, the possibility of generating escape mutants is a significant consideration when using CRISPR/Cas9 against any virus. This underlines the importance of adopting an appropriate design for gene editing strategies, but it does not detract from the promise of this approach in the treatment of human viral diseases.</p>
</sec>
</body>
<back>
<ack>
<p>We thank past and present members of the Department of Neuroscience for their continued support and insightful discussions. We also acknowledge the intellectual contributions of the Temple University School of Medicine Comprehensive NeuroAIDS Center (Basic Science Cores I and II). We are grateful to Cynthia Papaleo for editorial assistance.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ppat.1005953.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>White</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Khalili</surname> <given-names>K</given-names></name>. <article-title>CRISPR/Cas9 and cancer targets: future possibilities and present challenges</article-title>. <source>Oncotarget</source> <year>2016</year>; <volume>7</volume>: <fpage>12305</fpage>–<lpage>12317</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.18632/oncotarget.7104" xlink:type="simple">10.18632/oncotarget.7104</ext-link></comment> <object-id pub-id-type="pmid">26840090</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>White</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Khalili</surname> <given-names>K</given-names></name>. <article-title>The CRISPR/Cas9 genome editing methodology as a weapon against human viruses</article-title>. <source>Discov Med</source> <year>2015</year>; <volume>19</volume>: <fpage>255</fpage>–<lpage>262</lpage>. <object-id pub-id-type="pmid">25977188</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>YG</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Chandrasegaran</surname> <given-names>S</given-names></name>. <article-title>Insertion and deletion mutants of FokI restriction endonuclease</article-title>. <source>J Biol Chem</source>. <year>1994</year>; <volume>269</volume>: <fpage>31978</fpage>–<lpage>31982</lpage>. <object-id pub-id-type="pmid">7989374</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wright</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Spalding</surname> <given-names>MH</given-names></name>. <article-title>TALEN-mediated genome editing: prospects and perspectives</article-title>. <source>Biochem J</source>. <year>2014</year>; <volume>462</volume>: <fpage>15</fpage>–<lpage>24</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1042/BJ20140295" xlink:type="simple">10.1042/BJ20140295</ext-link></comment> <object-id pub-id-type="pmid">25057889</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Doudna</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Charpentier</surname> <given-names>E</given-names></name>. <article-title>Genome editing. The new frontier of genome engineering with CRISPR-Cas9</article-title>. <source>Science</source> <year>2014</year>; <volume>346</volume>: <fpage>1258096</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1258096" xlink:type="simple">10.1126/science.1258096</ext-link></comment> <object-id pub-id-type="pmid">25430774</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hsu</surname> <given-names>PD</given-names></name>, <name name-style="western"><surname>Lander</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>F</given-names></name>. <article-title>Development and applications of CRISPR-Cas9 for genome engineering</article-title>. <source>Cell</source> <year>2014</year>; <volume>157</volume>: <fpage>1262</fpage>–<lpage>1278</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cell.2014.05.010" xlink:type="simple">10.1016/j.cell.2014.05.010</ext-link></comment> <object-id pub-id-type="pmid">24906146</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Khalili</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kaminski</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Gordon</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Cosentino</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>W</given-names></name>. <article-title>Genome editing strategies: potential tools for eradicating HIV-1/AIDS</article-title>. <source>J Neurovirol</source>. <year>2015</year>; <volume>21</volume>: <fpage>310</fpage>–<lpage>321</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s13365-014-0308-9" xlink:type="simple">10.1007/s13365-014-0308-9</ext-link></comment> <object-id pub-id-type="pmid">25716921</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ran</surname> <given-names>FA</given-names></name>, <name name-style="western"><surname>Hsu</surname> <given-names>PD</given-names></name>, <name name-style="western"><surname>Wright</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Agarwala</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Scott</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>F</given-names></name>. <article-title>Genome engineering using the CRISPR-Cas9 system</article-title>. <source>Nat Protoc</source>. <year>2013</year>; <volume>8</volume>: <fpage>2281</fpage>–<lpage>2308</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nprot.2013.143" xlink:type="simple">10.1038/nprot.2013.143</ext-link></comment> <object-id pub-id-type="pmid">24157548</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Canver</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Bauer</surname> <given-names>DE</given-names></name>, <name name-style="western"><surname>Dass</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Yien</surname> <given-names>YY</given-names></name>, <name name-style="western"><surname>Chung</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Masuda</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells</article-title>. <source>J Biol Chem</source>. <year>2014</year>; <volume>289</volume>: <fpage>21312</fpage>–<lpage>21324</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M114.564625" xlink:type="simple">10.1074/jbc.M114.564625</ext-link></comment> <object-id pub-id-type="pmid">24907273</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moore</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Haber</surname> <given-names>JE</given-names></name>. <article-title>Cell cycle and genetic requirements of two pathways of nonhomologous end-joining repair of double-strand breaks in Saccharomyces cerevisiae</article-title>. <source>Mol Cell Biol</source>. <year>1996</year>; <volume>16</volume>: <fpage>2164</fpage>–<lpage>2173</lpage>. <object-id pub-id-type="pmid">8628283</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kennedy</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Kornepati</surname> <given-names>AV</given-names></name>, <name name-style="western"><surname>Goldstein</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bogerd</surname> <given-names>HP</given-names></name>, <name name-style="western"><surname>Poling</surname> <given-names>BC</given-names></name>, <name name-style="western"><surname>Whisnant</surname> <given-names>AW</given-names></name>, <etal>et al</etal>. <article-title>Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease</article-title>. <source>J Virol</source>. <year>2014</year>; <volume>88</volume>: <fpage>11965</fpage>–<lpage>11972</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JVI.01879-14" xlink:type="simple">10.1128/JVI.01879-14</ext-link></comment> <object-id pub-id-type="pmid">25100830</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hu</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Ding</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells</article-title>. <source>Biomed Res Int</source> <year>2014</year>; <volume>2014</volume>: <fpage>612823</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2014/612823" xlink:type="simple">10.1155/2014/612823</ext-link></comment> <object-id pub-id-type="pmid">25136604</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hua</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Narita</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>YH</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>. <article-title>In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2014</year>; <volume>450</volume>: <fpage>1422</fpage>–<lpage>1426</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbrc.2014.07.014" xlink:type="simple">10.1016/j.bbrc.2014.07.014</ext-link></comment> <object-id pub-id-type="pmid">25044113</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kennedy</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Bassit</surname> <given-names>LC</given-names></name>, <name name-style="western"><surname>Mueller</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kornepati</surname> <given-names>AV</given-names></name>, <name name-style="western"><surname>Bogerd</surname> <given-names>HP</given-names></name>, <name name-style="western"><surname>Nie</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease</article-title>. <source>Virology</source> <year>2015</year>; <volume>476</volume>: <fpage>196</fpage>–<lpage>205</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.virol.2014.12.001" xlink:type="simple">10.1016/j.virol.2014.12.001</ext-link></comment> <object-id pub-id-type="pmid">25553515</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>HC</given-names></name>, <name name-style="western"><surname>Kuo</surname> <given-names>YT</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>TY</given-names></name>, <name name-style="western"><surname>Sung</surname> <given-names>KC</given-names></name>, <etal>et al</etal>. <article-title>The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo</article-title>. <source>Mol Ther Nucleic Acids</source> <year>2014</year>; <volume>3</volume>: <fpage>e186</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/mtna.2014.38" xlink:type="simple">10.1038/mtna.2014.38</ext-link></comment> <object-id pub-id-type="pmid">25137139</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Seeger</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Sohn</surname> <given-names>JA</given-names></name>. <article-title>Targeting Hepatitis B Virus with CRISPR/Cas9</article-title>. <source>Mol Ther Nucleic Acids</source> <year>2014</year>; <volume>3</volume>: <fpage>e216</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/mtna.2014.68" xlink:type="simple">10.1038/mtna.2014.68</ext-link></comment> <object-id pub-id-type="pmid">25514649</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hua</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>YH</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>LC</given-names></name>, <name name-style="western"><surname>Fu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wan</surname> <given-names>DY</given-names></name>, <etal>et al</etal>. <article-title>Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus</article-title>. <source>Gene Ther</source> <year>2015</year>; <volume>22</volume>: <fpage>404</fpage>–<lpage>412</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/gt.2015.2" xlink:type="simple">10.1038/gt.2015.2</ext-link></comment> <object-id pub-id-type="pmid">25652100</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Quake</surname> <given-names>SR</given-names></name>. <article-title>RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection</article-title>. <source>Proc Natl Acad Sci USA</source> <year>2014</year>; <volume>111</volume>: <fpage>13157</fpage>–<lpage>13162</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1410785111" xlink:type="simple">10.1073/pnas.1410785111</ext-link></comment> <object-id pub-id-type="pmid">25157128</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yuen</surname> <given-names>KS</given-names></name>, <name name-style="western"><surname>Chan</surname> <given-names>CP</given-names></name>, <name name-style="western"><surname>Wong</surname> <given-names>NH</given-names></name>, <name name-style="western"><surname>Ho</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Ho</surname> <given-names>TH</given-names></name>, <name name-style="western"><surname>Lei</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells</article-title>. <source>J Gen Virol</source>. <year>2015</year>; <volume>96</volume>: <fpage>626</fpage>–<lpage>636</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1099/jgv.0.000012" xlink:type="simple">10.1099/jgv.0.000012</ext-link></comment> <object-id pub-id-type="pmid">25502645</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ebina</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Misawa</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Kanemura</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Koyanagi</surname> <given-names>Y</given-names></name>. <article-title>Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus</article-title>. <source>Sci Rep</source>. <year>2013</year>; <volume>3</volume>: <fpage>2510</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep02510" xlink:type="simple">10.1038/srep02510</ext-link></comment> <object-id pub-id-type="pmid">23974631</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Kaminski</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Cosentino</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection</article-title>. <source>Proc Natl Acad Sci USA</source> <year>2014</year>; <volume>111</volume>: <fpage>11461</fpage>–<lpage>11466</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1405186111" xlink:type="simple">10.1073/pnas.1405186111</ext-link></comment> <object-id pub-id-type="pmid">25049410</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kaminski</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Fischer</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Tedaldi</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Napoli</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Elimination of HIV-1 genomes from human T-lymphoid cells by CRISPR/Cas9 gene editing</article-title>. <source>Sci Rep</source>. <year>2016</year>; <volume>6</volume>: <fpage>22555</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep22555" xlink:type="simple">10.1038/srep22555</ext-link></comment> <object-id pub-id-type="pmid">26939770</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kaminski</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bella</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Yin</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Otte</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ferrante</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Gendelman</surname> <given-names>HE</given-names></name>, <etal>et al</etal>. <article-title>Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study</article-title>. <source>Gene Ther</source>. <year>2016</year>; <volume>23</volume>: <fpage>696</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/gt.2016.45" xlink:type="simple">10.1038/gt.2016.45</ext-link></comment> <object-id pub-id-type="pmid">27488023</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liao</surname> <given-names>HK</given-names></name>, <name name-style="western"><surname>Gu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Diaz</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Marlett</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells</article-title>. <source>Nat Commun</source>. <year>2015</year>; <volume>6</volume>: <fpage>6413</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncomms7413" xlink:type="simple">10.1038/ncomms7413</ext-link></comment> <object-id pub-id-type="pmid">25752527</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yin</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Putatunda</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Young</surname> <given-names>WB</given-names></name>, <etal>et al</etal>. <article-title>Functional screening of guide RNAs targeting the regulatory and structural HIV-1 viral genome for a cure of AIDS</article-title>. <source>AIDS</source> <year>2016</year>; <volume>30</volume>: <fpage>1163</fpage>–<lpage>1174</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/QAD.0000000000001079" xlink:type="simple">10.1097/QAD.0000000000001079</ext-link></comment> <object-id pub-id-type="pmid">26990633</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Lei</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Le Duff</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Wainberg</surname> <given-names>MA</given-names></name>, <etal>et al</etal>. <article-title>The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA</article-title>. <source>Retrovirology</source> <year>2015</year>; <volume>12</volume>: <fpage>22</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/s12977-015-0150-z" xlink:type="simple">10.1186/s12977-015-0150-z</ext-link></comment> <object-id pub-id-type="pmid">25808449</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kaminski</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Salkind</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bella</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Young</surname> <given-names>WB</given-names></name>, <name name-style="western"><surname>Ferrante</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Negative feedback regulation of HIV-1 by gene editing strategy</article-title>. <source>Sci Rep</source>. <year>2016</year>; <volume>6</volume>: <fpage>31527</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep31527" xlink:type="simple">10.1038/srep31527</ext-link></comment> <object-id pub-id-type="pmid">27528385</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wollebo</surname> <given-names>HS</given-names></name>, <name name-style="western"><surname>Bellizzi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kaminski</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>White</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Khalili</surname> <given-names>K</given-names></name>. <article-title>CRISPR/Cas9 System as an agent for eliminating Polyomavirus JC infection</article-title>. <source>PLoS ONE</source> <year>2015</year>; <volume>10</volume>: <fpage>e0136046</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0136046" xlink:type="simple">10.1371/journal.pone.0136046</ext-link></comment> <object-id pub-id-type="pmid">26360417</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Roehm</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Shekarabi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wollebo</surname> <given-names>HS</given-names></name>, <name name-style="western"><surname>Bellizzi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Salkind</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Inhibition of HSV-1 Replication by Gene Editing Strategy</article-title>. <source>Sci Rep</source>. <year>2016</year>; <volume>6</volume>: <fpage>23146</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep23146" xlink:type="simple">10.1038/srep23146</ext-link></comment> <object-id pub-id-type="pmid">27064617</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Diemen</surname> <given-names>FR</given-names></name>, <name name-style="western"><surname>Kruse</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Hooykaas</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Bruggeling</surname> <given-names>CE</given-names></name>, <name name-style="western"><surname>Schürch</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>van Ham</surname> <given-names>PM</given-names></name>, <etal>et al</etal>. <article-title>CRISPR/Cas9-mediated genome editing of herpesviruses limits productive and latent infections</article-title>. <source>PLoS Pathog</source>. <year>2016</year>; <volume>12</volume>: <fpage>e1005701</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1005701" xlink:type="simple">10.1371/journal.ppat.1005701</ext-link></comment> <object-id pub-id-type="pmid">27362483</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meinke</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Bohm</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hauber</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Pisabarro</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Buchholz</surname> <given-names>F</given-names></name>. <article-title>Cre Recombinase and other tyrosine recombinases</article-title>. <source>Chem Rev</source>. <year>2016</year>; In Press.</mixed-citation></ref>
<ref id="ppat.1005953.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Buchholz</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Stewart</surname> <given-names>AF</given-names></name>. <article-title>Alteration of Cre recombinase site specificity by substrate-linked protein evolution</article-title>. <source>Nat Biotechnol</source> <year>2001</year>; <volume>19</volume>: <fpage>1047</fpage>–<lpage>1052</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nbt1101-1047" xlink:type="simple">10.1038/nbt1101-1047</ext-link></comment> <object-id pub-id-type="pmid">11689850</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sarkar</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Hauber</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Hauber</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Buchholz</surname> <given-names>F</given-names></name>. <article-title>HIV-1 proviral DNA excision using an evolved recombinase</article-title>. <source>Science</source> <year>2007</year>; <volume>316</volume>: <fpage>1912</fpage>–<lpage>1915</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1141453" xlink:type="simple">10.1126/science.1141453</ext-link></comment> <object-id pub-id-type="pmid">17600219</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Buchholz</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Hauber</surname> <given-names>J</given-names></name>. <article-title>Engineered DNA modifying enzymes: components of a future strategy to cure HIV/AIDS</article-title>. <source>Antiviral Res</source>. <year>2013</year>; <volume>97</volume>: <fpage>211</fpage>–<lpage>217</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.antiviral.2012.12.017" xlink:type="simple">10.1016/j.antiviral.2012.12.017</ext-link></comment> <object-id pub-id-type="pmid">23267832</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hauber</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Hofmann-Sieber</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Chemnitz</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Dubrau</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Chusainow</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Stucka</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Highly significant antiviral activity of HIV-1 LTR-specific Tre-recombinase in humanized mice</article-title>. <source>PLoS Pathog</source>. <year>2013</year>; <volume>9</volume>: <fpage>e1003587</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1003587" xlink:type="simple">10.1371/journal.ppat.1003587</ext-link></comment> <object-id pub-id-type="pmid">24086129</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Karpinski</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hauber</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Chemnitz</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Schäfer</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Paszkowski-Rogacz</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chakraborty</surname> <given-names>D</given-names></name> <etal>et al</etal>. <article-title>Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity</article-title>. <source>Nat Biotechnol</source>. <year>2016</year>; <volume>34</volume>: <fpage>401</fpage>–<lpage>409</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nbt.3467" xlink:type="simple">10.1038/nbt.3467</ext-link></comment> <object-id pub-id-type="pmid">26900663</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Price</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Sampson</surname> <given-names>TR</given-names></name>, <name name-style="western"><surname>Ratner</surname> <given-names>HK</given-names></name>, <name name-style="western"><surname>Grakoui</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Weiss</surname> <given-names>DS</given-names></name>. <article-title>Cas9-mediated targeting of viral RNA in eukaryotic cells</article-title>. <source>Proc Natl Acad Sci USA</source> <year>2015</year>; <volume>112</volume>: <fpage>6164</fpage>–<lpage>6169</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1422340112" xlink:type="simple">10.1073/pnas.1422340112</ext-link></comment> <object-id pub-id-type="pmid">25918406</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Price</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Grakoui</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Weiss</surname> <given-names>DS</given-names></name>. <article-title>Harnessing the Prokaryotic Adaptive Immune System as a Eukaryotic Antiviral Defense</article-title>. <source>Trends Microbiol</source>. <year>2016</year>;<volume>24</volume>: <fpage>294</fpage>–<lpage>306</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.tim.2016.01.005" xlink:type="simple">10.1016/j.tim.2016.01.005</ext-link></comment> <object-id pub-id-type="pmid">26852268</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>De Silva Feelixge</surname> <given-names>HS</given-names></name>, <name name-style="western"><surname>Stone</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Pietz</surname> <given-names>HL</given-names></name>, <name name-style="western"><surname>Roychoudhury</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Greninger</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Schiffer</surname> <given-names>JT</given-names></name>, <etal>et al</etal>. <article-title>Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy</article-title>. <source>Antiviral Res</source>. <year>2016</year>; <volume>126</volume>: <fpage>90</fpage>–<lpage>98</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.antiviral.2015.12.007" xlink:type="simple">10.1016/j.antiviral.2015.12.007</ext-link></comment> <object-id pub-id-type="pmid">26718067</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Berkhout</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Das</surname> <given-names>AT</given-names></name>. <article-title>CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape</article-title>. <source>Mol Ther</source>. <year>2016</year>; <volume>24</volume>: <fpage>522</fpage>–<lpage>526</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/mt.2016.24" xlink:type="simple">10.1038/mt.2016.24</ext-link></comment> <object-id pub-id-type="pmid">26796669</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Pan</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Gendron</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Cen</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>CRISPR/Cas9-derived mutations both inhibit HIV-1 replication and accelerate viral escape</article-title>. <source>Cell Rep</source>. <year>2016</year>; <volume>15</volume>: <fpage>481</fpage>–<lpage>489</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.celrep.2016.03.042" xlink:type="simple">10.1016/j.celrep.2016.03.042</ext-link></comment> <object-id pub-id-type="pmid">27068471</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yoder</surname> <given-names>KE</given-names></name>, <name name-style="western"><surname>Bundschuh</surname> <given-names>R</given-names></name>. <article-title>Host double strand break repair generates HIV-1 strains resistant to CRISPR/Cas9</article-title>. <source>Sci Rep</source>. <year>2016</year>; <volume>6</volume>: <fpage>29530</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep29530" xlink:type="simple">10.1038/srep29530</ext-link></comment> <object-id pub-id-type="pmid">27404981</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bobbin</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Burnett</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Rossi</surname> <given-names>JJ</given-names></name>. <article-title>RNA interference approaches for treatment of HIV-1 infection</article-title>. <source>Genome Med</source>. <year>2015</year>; <volume>7</volume>: <fpage>50</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/s13073-015-0174-y" xlink:type="simple">10.1186/s13073-015-0174-y</ext-link></comment> <object-id pub-id-type="pmid">26019725</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Das</surname> <given-names>AT</given-names></name>, <name name-style="western"><surname>Brummelkamp</surname> <given-names>TR</given-names></name>, <name name-style="western"><surname>Westerhout</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Vink</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Madiredjo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bernards</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition</article-title>. <source>J Virol</source>. <year>2004</year>; <volume>78</volume>: <fpage>2601</fpage>–<lpage>2605</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JVI.78.5.2601-2605.2004" xlink:type="simple">10.1128/JVI.78.5.2601-2605.2004</ext-link></comment> <object-id pub-id-type="pmid">14963165</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ter Brake</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>von Eije</surname> <given-names>KJ</given-names></name>, <name name-style="western"><surname>Berkhout</surname> <given-names>B</given-names></name>. <article-title>Probing the sequence space available for HIV-1 evolution</article-title>. <source>AIDS</source> <year>2008</year>; <volume>22</volume>: <fpage>1875</fpage>–<lpage>1877</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/QAD.0b013e328309efe3" xlink:type="simple">10.1097/QAD.0b013e328309efe3</ext-link></comment> <object-id pub-id-type="pmid">18753935</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peng</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Ouyang</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Pang</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Pseudorabies virus can escape from CRISPR-Cas9-mediated inhibition</article-title>. <source>Virus Res</source>. <year>2016</year>; <volume>223</volume>: <fpage>197</fpage>–<lpage>205</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.virusres.2016.08.001" xlink:type="simple">10.1016/j.virusres.2016.08.001</ext-link></comment> <object-id pub-id-type="pmid">27507009</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Govindan</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Ramalingam</surname> <given-names>S</given-names></name>. <article-title>Programmable site-specific nucleases for targeted genome engineering in higher eukaryotes</article-title>. <source>J Cell Physiol</source>. <year>2016</year>; <volume>231</volume>: <fpage>2380</fpage>–<lpage>2392</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/jcp.25367" xlink:type="simple">10.1002/jcp.25367</ext-link></comment> <object-id pub-id-type="pmid">26945523</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kaulich</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Dowdy</surname> <given-names>SF</given-names></name>. <article-title>Combining CRISPR/Cas9 and rAAV templates for efficient gene editing</article-title>. <source>Nucleic Acid Ther</source>. <year>2015</year>; <volume>25</volume>: <fpage>287</fpage>–<lpage>296</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/nat.2015.0545" xlink:type="simple">10.1089/nat.2015.0545</ext-link></comment> <object-id pub-id-type="pmid">26540648</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rooney</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Chaudhuri</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Alt</surname> <given-names>FW</given-names></name>. <article-title>The role of the non-homologous end-joining pathway in lymphocyte development</article-title>. <source>Immunol Rev</source>. <year>2004</year>; <volume>200</volume>: <fpage>115</fpage>–<lpage>131</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.0105-2896.2004.00165.x" xlink:type="simple">10.1111/j.0105-2896.2004.00165.x</ext-link></comment> <object-id pub-id-type="pmid">15242400</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Felgentreff</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Du</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Weinacht</surname> <given-names>KG</given-names></name>, <name name-style="western"><surname>Dobbs</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Bartish</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Giliani</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Differential role of nonhomologous end joining factors in the generation, DNA damage response, and myeloid differentiation of human induced pluripotent stem cells</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2014</year>;<volume>111</volume>: <fpage>8889</fpage>–<lpage>8894</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1323649111" xlink:type="simple">10.1073/pnas.1323649111</ext-link></comment> <object-id pub-id-type="pmid">24889605</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bos</surname> <given-names>TJ</given-names></name>, <name name-style="western"><surname>De Bruyne</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Heirman</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Vanderkerken</surname> <given-names>K</given-names></name>. <article-title>In search of the most suitable lentiviral shRNA system</article-title>. <source>Curr Gene Ther</source>. <year>2009</year>; <volume>9</volume>: <fpage>192</fpage>–<lpage>211</lpage>. <object-id pub-id-type="pmid">19519364</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Johnson</surname> <given-names>KE</given-names></name>, <name name-style="western"><surname>Bottero</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Flaherty</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Dutta</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Singh</surname> <given-names>VV</given-names></name>, <name name-style="western"><surname>Chandran</surname> <given-names>B</given-names></name>. <article-title>IFI16 restricts HSV-1 replication by accumulating on the hsv-1 genome, repressing HSV-1 gene expression, and directly or indirectly modulating histone modifications</article-title>. <source>PLoS Pathog</source> <year>2014</year>; <volume>10</volume>: <fpage>e1004503</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1004503" xlink:type="simple">10.1371/journal.ppat.1004503</ext-link></comment> <object-id pub-id-type="pmid">25375629</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Turner</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Brown</surname> <given-names>RS</given-names></name>, <name name-style="western"><surname>Laudermilch</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Tsai</surname> <given-names>PL</given-names></name>, <name name-style="western"><surname>Schlieker</surname> <given-names>C</given-names></name>. <article-title>The Torsin Activator LULL1 Is Required for Efficient Growth of Herpes Simplex Virus 1</article-title>. <source>J Virol</source> <year>2015</year>; <volume>89</volume>, <fpage>8444</fpage>–<lpage>8452</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JVI.01143-15" xlink:type="simple">10.1128/JVI.01143-15</ext-link></comment> <object-id pub-id-type="pmid">26041288</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Ding</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells</article-title>. <source>Onco Targets Ther</source> <year>2014</year>; <volume>8</volume>: <fpage>37</fpage>–<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2147/OTT.S64092" xlink:type="simple">10.2147/OTT.S64092</ext-link></comment> <object-id pub-id-type="pmid">25565864</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>YC</given-names></name>, <name name-style="western"><surname>Cai</surname> <given-names>ZM</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>XJ</given-names></name>. <article-title>Reprogrammed CRISPR-Cas9 targeting the conserved regions of HPV6/11 E7 genes inhibits proliferation and induces apoptosis in E7-transformed keratinocytes</article-title>. <source>Asian J Androl</source> <year>2016</year>; <volume>18</volume>: <fpage>475</fpage>–<lpage>479</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4103/1008-682X.157399" xlink:type="simple">10.4103/1008-682X.157399</ext-link></comment> <object-id pub-id-type="pmid">26228041</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dong</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Qu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Dong</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Xiong</surname> <given-names>S</given-names></name>. <article-title>Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication</article-title>. <source>Antiviral Res</source> <year>2015</year>; <volume>118</volume>: <fpage>110</fpage>–<lpage>117</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.antiviral.2015.03.015" xlink:type="simple">10.1016/j.antiviral.2015.03.015</ext-link></comment> <object-id pub-id-type="pmid">25843425</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guo</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Hou</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>TY</given-names></name>, <etal>et al</etal>. <article-title>The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely</article-title>. <source>Sci Rep</source> <year>2016</year>; <volume>6</volume>: <fpage>25552</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep25552" xlink:type="simple">10.1038/srep25552</ext-link></comment> <object-id pub-id-type="pmid">27174254</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Hao</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Y</given-names></name>. <article-title>Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome</article-title>. <source>J Gen Virol</source> <year>2015</year>; <volume>96</volume>: <fpage>2252</fpage>–<lpage>2261</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1099/vir.0.000159" xlink:type="simple">10.1099/vir.0.000159</ext-link></comment> <object-id pub-id-type="pmid">25904148</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ramanan</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Shlomai</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Cox</surname> <given-names>DB</given-names></name>, <name name-style="western"><surname>Schwartz</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Michailidis</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Bhatta</surname> <given-names>A</given-names></name>, <etal>et al</etal> (2015). <article-title>CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus</article-title>. <source>Sci Rep</source> <year>2015</year>; <volume>5</volume>: <fpage>10833</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep10833" xlink:type="simple">10.1038/srep10833</ext-link></comment> <object-id pub-id-type="pmid">26035283</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Seeger</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Sohn</surname> <given-names>JA</given-names></name>. <article-title>Complete spectrum of CRISPR/Cas9-induced mutations on HBV cccDNA</article-title>. <source>Mol Ther</source> <year>2016</year>; <volume>24</volume>: <fpage>1258</fpage>–<lpage>1266</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/mt.2016.94" xlink:type="simple">10.1038/mt.2016.94</ext-link></comment> <object-id pub-id-type="pmid">27203444</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Xie</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse</article-title>. <source>Virus Res</source> <year>2016</year>; <volume>217</volume>: <fpage>125</fpage>–<lpage>132</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.virusres.2016.04.003" xlink:type="simple">10.1016/j.virusres.2016.04.003</ext-link></comment> <object-id pub-id-type="pmid">27049051</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>ZW</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>RY</given-names></name>, <name name-style="western"><surname>Ding</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Xie</surname> <given-names>XM</given-names></name>, <etal>et al</etal>. (2015). <article-title>Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication</article-title>. <source>World J Gastroenterol</source> <year>2015</year>; <volume>21</volume>: <fpage>9554</fpage>–<lpage>9565</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3748/wjg.v21.i32.9554" xlink:type="simple">10.3748/wjg.v21.i32.9554</ext-link></comment> <object-id pub-id-type="pmid">26327763</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Karimova</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Beschorner</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Dammermann</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Chemnitz</surname> <given-names>J</given-names></name>., <name name-style="western"><surname>Indenbirken</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Bockmann</surname> <given-names>JH</given-names></name>, <etal>et al</etal>. <article-title>CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X</article-title>. <source>Sci Rep</source> <year>2015</year>; <volume>5</volume>: <fpage>13734</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep13734" xlink:type="simple">10.1038/srep13734</ext-link></comment> <object-id pub-id-type="pmid">26334116</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hopcraft</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Azarm</surname> <given-names>KD</given-names></name>, <name name-style="western"><surname>Israelow</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Leveque</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Schwarz</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Hsu</surname> <given-names>TH</given-names></name>, <etal>et al</etal>. <article-title>Viral determinants of miR-122-independent Hepatitis C virus replication</article-title>. <source>mSphere</source> <year>2015</year>; <volume>1</volume>: <fpage>e00009</fpage>–<lpage>e00015</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/mSphere.00009-15" xlink:type="simple">10.1128/mSphere.00009-15</ext-link></comment> <object-id pub-id-type="pmid">27303683</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hopcraft</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Evans</surname> <given-names>MJ</given-names></name> (2015). <article-title>Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins</article-title>. <source>Hepatology</source> <year>2015</year>; <volume>62</volume>: <fpage>1059</fpage>–<lpage>1069</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/hep.27815" xlink:type="simple">10.1002/hep.27815</ext-link></comment> <object-id pub-id-type="pmid">25820616</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shirasago</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Shimizu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Tanida</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Suzuki</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Suzuki</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Sugiyama</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Occludin-knockout human hepatic Huh7.5.1-8-derived cells are completely resistant to Hepatitis C virus infection</article-title>. <source>Biol Pharm Bull</source> <year>2016</year>; <volume>39</volume>: <fpage>839</fpage>–<lpage>848</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1248/bpb.b15-01023" xlink:type="simple">10.1248/bpb.b15-01023</ext-link></comment> <object-id pub-id-type="pmid">26887345</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kanda</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Furuse</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Oshitani</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kiyono</surname> <given-names>T</given-names></name>. <article-title>Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains</article-title>. <source>J Virol</source> <year>2016</year>; <volume>90</volume>: <fpage>4383</fpage>–<lpage>4393</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JVI.00060-16" xlink:type="simple">10.1128/JVI.00060-16</ext-link></comment> <object-id pub-id-type="pmid">26889033</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref068"><label>68</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ueda</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ebina</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kanemura</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Misawa</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Koyanagi</surname> <given-names>Y</given-names></name>. <article-title>Insufficient anti-HIV-1 potency of the CRISPR/Cas9 system for full viral replication</article-title>. <source>Microbiol Immunol</source>. <year>2016</year>; <volume>60</volume>: <fpage>483</fpage>–<lpage>496</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/1348-0421.12395" xlink:type="simple">10.1111/1348-0421.12395</ext-link></comment> <object-id pub-id-type="pmid">27278725</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref069"><label>69</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yan</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Liang</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kamata</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>IS</given-names></name>. <article-title>Modulation of gene expression by polymer nanocapsule delivery of DNA cassettes encoding small RNAs</article-title>. <source>PLoS ONE</source> <year>2015</year>; <volume>10</volume>: <fpage>e0127986</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0127986" xlink:type="simple">10.1371/journal.pone.0127986</ext-link></comment> <object-id pub-id-type="pmid">26035832</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref070"><label>70</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bonifati</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Daly</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>St Gelais</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Hollenbaugh</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Shepard</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>SAMHD1 controls cell cycle status, apoptosis and HIV-1 infection in monocytic THP-1 cells</article-title>. <source>Virology</source> <year>2016</year>; <volume>495</volume>: <fpage>92</fpage>–<lpage>100</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.virol.2016.05.002" xlink:type="simple">10.1016/j.virol.2016.05.002</ext-link></comment> <object-id pub-id-type="pmid">27183329</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref071"><label>71</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hou</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection</article-title>. <source>Sci Rep</source>. <year>2015</year>;<volume>5</volume>:<fpage>15577</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep15577" xlink:type="simple">10.1038/srep15577</ext-link></comment> <object-id pub-id-type="pmid">26481100</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref072"><label>72</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hutter</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Bodor</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ledger</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Boyd</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Millington</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tsie</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape</article-title>. <source>Viruses</source> <year>2015</year>; <volume>7</volume>: <fpage>4186</fpage>–<lpage>4203</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3390/v7082816" xlink:type="simple">10.3390/v7082816</ext-link></comment> <object-id pub-id-type="pmid">26225991</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref073"><label>73</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Minder</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Mesquitta</surname> <given-names>WT</given-names></name>, <name name-style="western"><surname>Torbett</surname> <given-names>BE</given-names></name>, <article-title>Slukvin II CCR5 disruption in induced pluripotent stem cells using CRISPR/Cas9 Provides selective resistance of immune cells to CCR5-tropic HIV-1 virus</article-title>. <source>Mol Ther Nucleic Acids</source> <year>2015</year>; <volume>4</volume>: <fpage>e268</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/mtna.2015.42" xlink:type="simple">10.1038/mtna.2015.42</ext-link></comment> <object-id pub-id-type="pmid">26670276</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref074"><label>74</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Guan</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Du</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Jin</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9</article-title>. <source>J Gen Virol</source> <year>2016</year>; <volume>96</volume>: <fpage>2381</fpage>–<lpage>2393</lpage>.</mixed-citation></ref>
<ref id="ppat.1005953.ref075"><label>75</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Ye</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Kimata</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>P</given-names></name>. <article-title>CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection</article-title>. <source>PLoS ONE</source> <year>2014</year>; <volume>9</volume>: <fpage>e115987</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0115987" xlink:type="simple">10.1371/journal.pone.0115987</ext-link></comment> <object-id pub-id-type="pmid">25541967</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref076"><label>76</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liang</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Wainberg</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Das</surname> <given-names>AT</given-names></name>, <name name-style="western"><surname>Berkhout</surname> <given-names>B</given-names></name>. <article-title>CRISPR/Cas9: a double-edged sword when used to combat HIV infection</article-title>. <source>Retrovirology</source> <year>2016</year>; <volume>13</volume>: <fpage>37</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/s12977-016-0270-0" xlink:type="simple">10.1186/s12977-016-0270-0</ext-link></comment> <object-id pub-id-type="pmid">27230886</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref077"><label>77</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zetsche</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Gootenberg</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Abudayyeh</surname> <given-names>OO</given-names></name>, <name name-style="western"><surname>Slaymaker</surname> <given-names>IM</given-names></name>, <name name-style="western"><surname>Makarova</surname> <given-names>KS</given-names></name>, <name name-style="western"><surname>Essletzbichler</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system</article-title>. <source>Cell</source> <year>2015</year>; <volume>163</volume>: <fpage>759</fpage>–<lpage>771</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cell.2015.09.038" xlink:type="simple">10.1016/j.cell.2015.09.038</ext-link></comment> <object-id pub-id-type="pmid">26422227</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref078"><label>78</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yamano</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Nishimasu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Zetsche</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Hirano</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Slaymaker</surname> <given-names>IM</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Crystal structure of Cpf1 in complex with guide RNA and target DNA</article-title>. <source>Cell</source> <year>2016</year>; <volume>165</volume>: <fpage>949</fpage>–<lpage>962</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cell.2016.04.003" xlink:type="simple">10.1016/j.cell.2016.04.003</ext-link></comment> <object-id pub-id-type="pmid">27114038</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref079"><label>79</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Swamy</surname> <given-names>MN</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Shankar</surname> <given-names>P</given-names></name>. <article-title>Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS</article-title>. <source>Adv Drug Deliv Rev</source>. <year>2016</year>; pii:S0169-409X(16)30091-6.</mixed-citation></ref>
<ref id="ppat.1005953.ref080"><label>80</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gish</surname> <given-names>RG</given-names></name>, <name name-style="western"><surname>Yuen</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Chan</surname> <given-names>HL</given-names></name>, <name name-style="western"><surname>Given</surname> <given-names>BD</given-names></name>, <name name-style="western"><surname>Lai</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Locarnini</surname> <given-names>SA</given-names></name>, <etal>et al</etal>. <article-title>Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent</article-title>. <source>Antiviral Res</source>. <year>2015</year>; <volume>121</volume>: <fpage>97</fpage>–<lpage>108</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.antiviral.2015.06.019" xlink:type="simple">10.1016/j.antiviral.2015.06.019</ext-link></comment> <object-id pub-id-type="pmid">26129970</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref081"><label>81</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Verstegen</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Pan</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>van der Laan</surname> <given-names>LJ</given-names></name>. <article-title>Gene therapies for hepatitis C virus</article-title>. <source>Adv Exp Med Biol</source> <year>2015</year>; <volume>848</volume>: <fpage>1</fpage>–<lpage>29</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/978-1-4939-2432-5_1" xlink:type="simple">10.1007/978-1-4939-2432-5_1</ext-link></comment> <object-id pub-id-type="pmid">25757613</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref082"><label>82</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jung</surname> <given-names>HS</given-names></name>, <name name-style="western"><surname>Rajasekaran</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Ju</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Shin</surname> <given-names>YK</given-names></name>. <article-title>Human papillomavirus: current and future RNAi Therapeutic strategies for cervical cancer</article-title>. <source>J Clin Med</source>. <year>2015</year>; <volume>4</volume>: <fpage>1126</fpage>–<lpage>1155</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3390/jcm4051126" xlink:type="simple">10.3390/jcm4051126</ext-link></comment> <object-id pub-id-type="pmid">26239469</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref083"><label>83</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jung</surname> <given-names>HS</given-names></name>, <name name-style="western"><surname>Rajasekaran</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Song</surname> <given-names>SY</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>YD</given-names></name>, <name name-style="western"><surname>Hong</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>HJ</given-names></name>, <etal>et al</etal>. <article-title>Human papillomavirus E6/E7-specific siRNA potentiates the effect of radiotherapy for cervical cancer in vitro and in vivo</article-title>. <source>Int J Mol Sci</source>. <year>2015</year>; <volume>16</volume>: <fpage>12243</fpage>–<lpage>12260</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3390/ijms160612243" xlink:type="simple">10.3390/ijms160612243</ext-link></comment> <object-id pub-id-type="pmid">26035754</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref084"><label>84</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Radhakrishnan</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Gordon</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Del Valle</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Cui</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Khalili</surname> <given-names>K</given-names></name>. <article-title>Intracellular approach for blocking JC virus gene expression by using RNA interference during viral infection</article-title>. <source>J Virol</source>. <year>2004</year>; <volume>78</volume>: <fpage>7264</fpage>–<lpage>7269</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JVI.78.13.7264-7269.2004" xlink:type="simple">10.1128/JVI.78.13.7264-7269.2004</ext-link></comment> <object-id pub-id-type="pmid">15194802</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref085"><label>85</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Paavilainen</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Lehtinen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Romanovskaya</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Nygårdas</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bamford</surname> <given-names>DH</given-names></name>, <name name-style="western"><surname>Poranen</surname> <given-names>MM</given-names></name>, <etal>et al</etal>. <article-title>Inhibition of clinical pathogenic herpes simplex virus 1 strains with enzymatically created siRNA pools</article-title>. <source>J Med Virol</source>. <year>2016</year>;<volume>88</volume>(<issue>12</issue>):<fpage>2196</fpage>–<lpage>2205</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/jmv.24578" xlink:type="simple">10.1002/jmv.24578</ext-link></comment> <object-id pub-id-type="pmid">27191509</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref086"><label>86</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ye</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Beyer</surname> <given-names>AI</given-names></name>, <name name-style="western"><surname>Teque</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Cradick</surname> <given-names>TJ</given-names></name>, <name name-style="western"><surname>Qi</surname> <given-names>Z</given-names></name>, <etal>et al</etal>. <article-title>Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection</article-title>. <source>Proc Natl Acad Sci USA</source> <year>2014</year>; <volume>111</volume>: <fpage>9591</fpage>–<lpage>9596</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1407473111" xlink:type="simple">10.1073/pnas.1407473111</ext-link></comment> <object-id pub-id-type="pmid">24927590</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref087"><label>87</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saayman</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Lazar</surname> <given-names>DC</given-names></name>, <name name-style="western"><surname>Scott</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Hart</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Burnett</surname> <given-names>JC</given-names></name>, <etal>et al</etal>. <article-title>Potent and targeted activation of latent HIV-1 using the CRISPR/dCas9 activator complex</article-title>. <source>Mol Ther</source>. <year>2016</year>; <volume>24</volume>: <fpage>488</fpage>–<lpage>498</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/mt.2015.202" xlink:type="simple">10.1038/mt.2015.202</ext-link></comment> <object-id pub-id-type="pmid">26581162</object-id></mixed-citation></ref>
<ref id="ppat.1005953.ref088"><label>88</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yin</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Kaminski</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs</article-title>. <source>Sci Rep</source>. <year>2015</year>; <volume>5</volume>: <fpage>16277</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep16277" xlink:type="simple">10.1038/srep16277</ext-link></comment> <object-id pub-id-type="pmid">26538064</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>